Scholarlink

<p>This study investigates the expression and functional significance of mitochondrial ribosomal protein S12 (MRPS12) within NSCLC pathogenesis. The Cancer Genome Atlas dataset reveals a significant association between <i>MRPS12</i> overexpression and unfavorable clinical outcomes in NSCLC patients. Single-cell RNA sequencing data unequivocally confirm <i>MRPS12</i> overexpression across diverse NSCLC cancer cell populations. MRPS12 is also upregulated in locally-treated NSCLC tissues. shRNA-mediated gene silencing or CRISPR-Cas9-mediated gene knockout (KO) of MRPS12 impaired mitochondrial function, resulting in a reduction in oxygen consumption rate, marked declines of complex I activity and ATP levels, mitochondrial membrane depolarization, and an increase in reactive oxygen species production in NSCLC cells. Moreover, MRPS12 silencing or knockout attenuated cell viability, proliferation, and migratory capacity, while inducing apoptotic cell death in various NSCLC cell types. Conversely, ectopic MRPS12 overexpression conferred a pro-tumorigenic phenotype to NSCLC cells. In vivo studies demonstrated that MRPS12 silencing markedly inhibited the growth of subcutaneous xenografts derived from primary NSCLC cells in nude mice. The MRPS12-silenced NSCLC xenografts exhibited decreased ATP levels, elevated oxidative injury, diminished proliferation, inhibited Akt-mTOR activation and an increase in apoptosis. These findings support the important role of MRPS12 in supporting mitochondrial function and driving the malignant progression of NSCLC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Exploring mitochondrial ribosomal protein S12 as a novel target for non-small cell lung cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月14日

查看全文
  • Zihao Chen,
  • Yu Jin,
  • Shiyou Wei,
  • Rongqiang Wei,
  • Xinyu Ding

摘要

This study investigates the expression and functional significance of mitochondrial ribosomal protein S12 (MRPS12) within NSCLC pathogenesis. The Cancer Genome Atlas dataset reveals a significant association between MRPS12 overexpression and unfavorable clinical outcomes in NSCLC patients. Single-cell RNA sequencing data unequivocally confirm MRPS12 overexpression across diverse NSCLC cancer cell populations. MRPS12 is also upregulated in locally-treated NSCLC tissues. shRNA-mediated gene silencing or CRISPR-Cas9-mediated gene knockout (KO) of MRPS12 impaired mitochondrial function, resulting in a reduction in oxygen consumption rate, marked declines of complex I activity and ATP levels, mitochondrial membrane depolarization, and an increase in reactive oxygen species production in NSCLC cells. Moreover, MRPS12 silencing or knockout attenuated cell viability, proliferation, and migratory capacity, while inducing apoptotic cell death in various NSCLC cell types. Conversely, ectopic MRPS12 overexpression conferred a pro-tumorigenic phenotype to NSCLC cells. In vivo studies demonstrated that MRPS12 silencing markedly inhibited the growth of subcutaneous xenografts derived from primary NSCLC cells in nude mice. The MRPS12-silenced NSCLC xenografts exhibited decreased ATP levels, elevated oxidative injury, diminished proliferation, inhibited Akt-mTOR activation and an increase in apoptosis. These findings support the important role of MRPS12 in supporting mitochondrial function and driving the malignant progression of NSCLC.